Literature DB >> 12106858

Usefulness of endothelin-1 concentration in capillary blood in patients with mitral stenosis as a predictor of regression of pulmonary hypertension after mitral valve replacement or valvuloplasty.

Grazyna Snopek1, Hanna Pogorzelska, Tomasz M Rywik, Aldona Browarek, Jadwiga Janas, Jerzy Korewicki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12106858     DOI: 10.1016/s0002-9149(02)02451-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  6 in total

Review 1.  Models and Molecular Mechanisms of World Health Organization Group 2 to 4 Pulmonary Hypertension.

Authors:  Ping Yu Xiong; Francois Potus; Winnie Chan; Stephen L Archer
Journal:  Hypertension       Date:  2017-11-20       Impact factor: 10.190

Review 2.  WHO's in second?: A practical review of World Health Organization group 2 pulmonary hypertension.

Authors:  Sif Hansdottir; Dayna J Groskreutz; Brian K Gehlbach
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

3.  Secondary pulmonary hypertension: haemodynamic effects of torasemide versus furosemide.

Authors:  Vera von Dossow; Claudia Spies; Hannes Schenk; Sabine Schlesinger; Christian von Heymann
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

4.  Pulmonary hypertension related to left-sided cardiac pathology.

Authors:  Todd L Kiefer; Thomas M Bashore
Journal:  Pulm Med       Date:  2011-05-29

5.  Persistence of pulmonary arterial hypertension after relief of left sided obstructive lesions in small infants: our experience.

Authors:  T Munesh
Journal:  Images Paediatr Cardiol       Date:  2017 Jan-Mar

Review 6.  The Biological Bases of Group 2 Pulmonary Hypertension.

Authors:  Ana I Fernández; Raquel Yotti; Ana González-Mansilla; Teresa Mombiela; Enrique Gutiérrez-Ibanes; Candelas Pérez Del Villar; Paula Navas-Tejedor; Christian Chazo; Pablo Martínez-Legazpi; Francisco Fernández-Avilés; Javier Bermejo
Journal:  Int J Mol Sci       Date:  2019-11-23       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.